Quick Answer
Greenwich LifeSciences, Inc. reported Net Income of -$15.79 million for fiscal year 2024.
Greenwich LifeSciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$15.79M | -77.6% |
| 2023 | -$8.89M | -13.6% |
| 2022 | -$7.83M | -71.2% |
| 2021 | -$4.57M | -145.3% |
| 2020 | -$1.86M | +45.6% |
| 2019 | -$3.43M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.15M | -55.6% | -3.1% |
| June 30, 2025 | -$4.03M | -54.4% | -23.5% |
| March 31, 2025 | -$3.26M | -31.7% | -22.1% |
| September 30, 2024 | -$2.67M | -11.6% | -2.4% |
| June 30, 2024 | -$2.61M | -60.1% | -5.4% |
| March 31, 2024 | -$2.47M | -16.4% | -3.4% |
| September 30, 2023 | -$2.39M | -3.1% | -46.9% |
| June 30, 2023 | -$1.63M | -118.3% | +23.4% |
- Greenwich LifeSciences, Inc. showed a decrease of -77.6% in Net Income compared to the prior fiscal year.
- Over the 2019–2024 period, Greenwich LifeSciences, Inc.’s net income has declined by 360.9% (from -$3.43 million to -$15.79 million).
- The most recent figure is from Greenwich LifeSciences, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: